`A group of researchers claim that they are patenting a possible cure for cancer involving nothing more than sugar and short-chain fatty acid combination.
The Johns Hopkins researchers cautioned that their double-punch molecule, described in the December issue of the journal Chemistry & Biology, has not yet been tested on animals or humans. [..]
The researchers focused on a sugar called N-acetyl-D-mannosamine, or ManNAc, for short, and created a hybrid molecule by linking ManNAc with butyrate.
The hybrid easily penetrates a cell’s surface, then is split apart by enzymes inside the cell.’